Albor, Fe A.
HRN: 28-27-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CEFTRIAXONE 1G (VIAL)
12/12/2025
12/19/2025
IV
2g
Od
Uti, Ptb Presumptive
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes